Smurfit Westrock (SW) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
11 Mar, 2026Executive summary
Achieved strong operational and financial results in 2025, with $31.2B net sales, $4.9B adjusted EBITDA, and $1.5B adjusted free cash flow, exceeding synergy targets post-Combination.
Maintained a performance-driven, customer-centric culture, emphasizing safety, accountability, and continuous improvement.
Returned capital to shareholders via quarterly dividends, including a 5% increase in February 2026.
Announced a Medium-Term Plan through 2030 to guide disciplined capital allocation and drive improved financial performance.
Continued robust shareholder engagement and transparency, with over 450 investor meetings in 2025.
Voting matters and shareholder proposals
Election of 12 director nominees for one-year terms.
Advisory vote to approve named executive officer compensation.
Ratification of KPMG as independent auditor for 2026 and authorization for the Audit Committee to set remuneration.
Renewal of Board authority to issue shares and opt out of statutory pre-emption rights under Irish law.
Determination of price range for re-issuing treasury shares.
Board of directors and corporate governance
Board comprises 12 directors post-AGM, with 83% independence and a 50% gender split.
Board committees (Audit, Compensation, Nomination, Finance, Sustainability) are fully independent.
Annual board and committee evaluations, including an external review in 2025.
Shareholders holding 10%+ of shares can call special meetings; one class of voting stock with equal rights.
No poison pill or supermajority vote provisions beyond Irish law.
Latest events from Smurfit Westrock
- Targets $7bn Adjusted EBITDA and ~19% margin by 2030, with strong capital returns and global growth.SW
Investor presentation11 Mar 2026 - AGM to vote on directors, compensation, auditor, and share issuance; board recommends approval.SW
Proxy Filing11 Mar 2026 - Q4 net sales $7.58B, $4.94B Adjusted EBITDA; 2026 EBITDA guidance $5–$5.3B.SW
Q4 202511 Feb 2026 - Merger creates global leader; Q2 net income falls, but integration and synergies drive outlook.SW
Q2 20242 Feb 2026 - Q3 sales hit $7.7B, Adjusted EBITDA $1.27B, but one-time costs led to a $150M net loss.SW
Q3 202417 Jan 2026 - Q4 net sales $7.5B, $1.17B EBITDA, $400M synergies, and 42% dividend increase achieved.SW
Q4 20248 Jan 2026 - Q1 2025 Adjusted EBITDA rose 163% to $1.252B, with strong synergy and integration progress.SW
Q1 20256 Jan 2026 - Shareholders to vote on directors, executive pay, auditor, and key governance proposals.SW
Proxy Filing2 Dec 2025 - AGM to vote on directors, executive pay, auditor, and key share issuance proposals.SW
Proxy Filing2 Dec 2025